Gluvan Plus | 50+500mg Tablet | 1 Strip

✔️ Side Effects

Common effects include headache, dizziness, tremor, nausea, and low blood sugar.

✔️ Dosage & Administration:

Adults: Dose depends on the patient’s current Metformin regimen. Typically taken twice daily—one tablet in the morning and one in the evening—with food to reduce gastrointestinal side effects. Patients switching from separate tablets may start with equivalent doses in the combination form. Daily vildagliptin dose should not exceed 100 mg. No clinical data support triple therapy with other antidiabetics.

Children: Not recommended under 18 years.

Elderly: Monitor kidney function regularly; use only if renal function is normal.

Renal impairment: Avoid if serum creatinine >1.5 mg/dL (men) or >1.4 mg/dL (women).

Hepatic impairment: Not recommended if baseline liver enzymes are >3× upper normal limit.

✔️ Drug Interactions

No significant interaction between vildagliptin and metformin has been found. Vildagliptin is not metabolized by, nor does it affect, CYP450 enzymes, so it is unlikely to interfere with drugs processed by this pathway. It shows no major interactions with common medications like glibenclamide, pioglitazone, amlodipine, digoxin, ramipril, simvastatin, valsartan, or warfarin. However, drugs like furosemide, nifedipine, and glyburide can raise metformin levels in the blood without affecting its kidney clearance.

✔️ Contraindications:

Not to be used in patients allergic to either component, with kidney disease or dysfunction, acute myocardial infarction, septicemia, heart failure, or metabolic acidosis (including diabetic ketoacidosis). Avoid in those undergoing imaging with iodinated contrast, as it may cause sudden kidney issues.

✔️ Pregnancy & Lactation

Use only if potential benefits outweigh risks, as safety in pregnancy is unproven. It is unknown if the drugs pass into breast milk; therefore, avoid during breastfeeding.

✔️ Precautions & Warnings

Risk of lactic acidosis from metformin accumulation—stop treatment immediately if suspected and hospitalize the patient. Monitor kidney function annually (more often in elderly or borderline cases). Liver function tests should be checked before starting, every 3 months in the first year, and periodically thereafter. Discontinue if persistent liver enzyme elevation or signs of liver damage occur. Stop treatment 48 hours before surgery with general anesthesia and restart only after at least 48 hours.

✔️ Storage

Store in a cool, dry place, away from heat and light. Keep out of children’s reach.